COPD Therapeutics in Asia-Pacific Market Valued at $6.7 Billion in 2023 - Growth Driven by Rising Prevalence, Growing Awareness and Expected Launch of Novel Therapies
Chronic obstructive pulmonary disease (COPD) is a term that refers to a large group of lung diseases characterized by obstruction of air flow that interferes with normal breathing. It occurs most often in older people, but can also affect the middle aged population. COPD is a major cause of chronic morbidity and mortality globally. Many people suffer from the disease for years and eventually die from it or its complications, meaning it constitutes a substantial economic and social burden. Globally,...
View full press release